Literature DB >> 8520525

Protective effect of Saccharomyces boulardii against the cholera toxin in rats.

R S Dias1, E A Bambirra, M E Silva, J R Nicoli.   

Abstract

The effect of orogastric administration of Saccharomyces boulardii on the anatomopathological aspect of the jejunal villi was studied in male Fischer rats (weighing about 40 g) orogastrically infected with a culture of Vibrio cholerae. Experimental and control groups received lyophilized S. boulardii (25 mg suspended in 0.5 ml saline) or 0.5 ml saline, respectively, three times a day for 10 days by gastric intubation. On day 5 of treatment, 0.5 ml of a culture of V. cholerae containing 10(8) viable cells was inoculated by gastric intubation into both groups. Histopathological examination of the jejunal mucosa showed extensive lesions of the superficial epithelium of the villi from the control group whereas few lesions of this superficial epithelium were observed in the experimental group. These data show that the inhibition of the action of the cholera toxin on enterocytes by S. boulardii suggested by recent results in vitro can be demonstrated in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520525

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  8 in total

1.  Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells.

Authors:  D Czerucka; P Rampal
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae.

Authors:  R L Brandão; I M Castro; E A Bambirra; S C Amaral; L G Fietto; M J Tropia; M J Neves; R G Dos Santos; N C Gomes; J R Nicoli
Journal:  Appl Environ Microbiol       Date:  1998-02       Impact factor: 4.792

Review 3.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

4.  Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.

Authors:  A Qamar; S Aboudola; M Warny; P Michetti; C Pothoulakis; J T LaMont; C P Kelly
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Saccharomyces boulardii in maintenance treatment of Crohn's disease.

Authors:  M Guslandi; G Mezzi; M Sorghi; P A Testoni
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

6.  Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.

Authors:  Karen L Mumy; Xinhua Chen; Ciarán P Kelly; Beth A McCormick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-11-21       Impact factor: 4.052

7.  Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.

Authors:  Johnathan Sheele; Jessica Cartowski; Angela Dart; Arjun Poddar; Shikha Gupta; Eric Stashko; Bhaskara S Ravi; Crawford Nelson; Ajay Gupta
Journal:  Pathog Glob Health       Date:  2015-08-11       Impact factor: 2.894

8.  Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.

Authors:  Xinhua Chen; Guoxun Yang; Joo-Hye Song; Hua Xu; Dan Li; Jeffrey Goldsmith; Huiyan Zeng; Patricia A Parsons-Wingerter; Hans-Christian Reinecker; Ciaran P Kelly
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.